Pinto, A.; Guarini, C.; Giampaglia, M.; Sanna, V.; Melaccio, A.; Lanotte, L.; Santoro, A.N.; Pini, F.; Cusmai, A.; Giuliani, F.;
et al. Synergizing Immunotherapy and Antibody–Drug Conjugates: New Horizons in Breast Cancer Therapy. Pharmaceutics 2024, 16, 1146.
https://doi.org/10.3390/pharmaceutics16091146
AMA Style
Pinto A, Guarini C, Giampaglia M, Sanna V, Melaccio A, Lanotte L, Santoro AN, Pini F, Cusmai A, Giuliani F,
et al. Synergizing Immunotherapy and Antibody–Drug Conjugates: New Horizons in Breast Cancer Therapy. Pharmaceutics. 2024; 16(9):1146.
https://doi.org/10.3390/pharmaceutics16091146
Chicago/Turabian Style
Pinto, Antonello, Chiara Guarini, Marianna Giampaglia, Valeria Sanna, Assunta Melaccio, Laura Lanotte, Anna Natalizia Santoro, Francesca Pini, Antonio Cusmai, Francesco Giuliani,
and et al. 2024. "Synergizing Immunotherapy and Antibody–Drug Conjugates: New Horizons in Breast Cancer Therapy" Pharmaceutics 16, no. 9: 1146.
https://doi.org/10.3390/pharmaceutics16091146
APA Style
Pinto, A., Guarini, C., Giampaglia, M., Sanna, V., Melaccio, A., Lanotte, L., Santoro, A. N., Pini, F., Cusmai, A., Giuliani, F., Gadaleta-Caldarola, G., & Fedele, P.
(2024). Synergizing Immunotherapy and Antibody–Drug Conjugates: New Horizons in Breast Cancer Therapy. Pharmaceutics, 16(9), 1146.
https://doi.org/10.3390/pharmaceutics16091146
